Nineteen years of experience with autotransfusion for elective surgery in children: more troublesome than we expected

Tetsunori Tasaki1, Hitoshi Ohto

  • 1Department of Laboratory Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka City, Iwate 020-8505, Japan. ttasaki@jikei.ac.jp

Transfusion
|July 28, 2007
PubMed

Insights

Pediatric autologous blood donation poses risks, with 17.3% of child donors experiencing issues like vasovagal reactions. Aggressive donation strategies should be avoided to ensure children's safety in blood donation programs.

Area of Science:

  • Pediatric Transfusion Medicine
  • Blood Donor Safety
  • Surgical Patient Management

Background:

  • Autologous blood donation in children undergoing elective surgery is often pursued due to their long life expectancy.
  • However, this practice carries potential risks and complications, contrasting with the low risks associated with homologous blood transfusions.
  • Previous reports have documented issues arising from aggressive donation protocols, even in infants.

Purpose of the Study:

  • To assess the safety and complication rates of autologous blood donation in pediatric patients.
  • To evaluate the incidence of donation-related problems in children compared to adults.
  • To provide recommendations for safer pediatric autologous blood donation programs.

Main Methods:

  • A retrospective study involving 314 children under 16 years old who underwent autologous blood donation assessments between 1987 and 2005.
  • Data were collected from blood transfusion services at two Japanese university hospitals.
  • Follow-up extended over a 19-year period to track donation-related problems.

Main Results:

  • Seven children (2.2%) were unsuitable as donors, primarily due to uncooperative behavior.
  • A significant rate of 17.3% of children experienced donation-related problems, higher than the 6% rate in adult donors.
  • Nine children suffered severe complications, including vasovagal reactions, with one requiring vasopressor medication.

Conclusions:

  • Pediatric autologous blood donation can lead to significant complications, including hypotension in 17% of cases.
  • While advanced devices have improved the procedure, managing children's anxiety and tension is crucial for safety.
  • Aggressive donation practices in pediatric autologous blood donation programs should be discouraged.
Abstract

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...